$CPB

Campbell’s Share Price Slide Puts the Buffett Test to Work

Campbell Soup (CPB) shares have fallen 46% over five years, contrasting with the Nasdaq's 79% gain. The company's P/E ratio is 9.65, 51.9% below its 10-year average. FY2025 net sales were $10.3 billion, with earnings of $2.01 per share. However, the dividend payout ratio is 119%, and earnings are declining. The company is resetting its dividend to strengthen its balance sheet, which may impact the 6.8% yield.

Original reporting
Published Sep 13, 2026, 7:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 13, 2026, 7:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Campbell’s Share Price Slide Puts the Buffett Test to Work — source image
Decision brief

The 30-second read

$CPBBearishMed
01

Why it matters

Earnings decline and dividend concerns may pressure CPB stock, likely prompting a short‑term sell‑off.

02

Market read

Campbell Soup's deteriorating fundamentals could affect consumer staples sector sentiment.

03

What to watch

Potential new product launches or pricing power could improve margins.

Relevance 9/10Novelty 9/10Timing: post FY2025 10-K filing

Background

Article reviews Campbell Soup's recent FY2025 results, FY2026 Q1 performance, and dividend reset, questioning sustainability.

Company-level read

Ticker impact

$CPBBearishHigh confidence
Context

Campbell Soup reported FY2025 net sales of $10.3B, FY2025 earnings of $602M, and FY2026 Q1 earnings decline with a payout ratio over 100%, indicating dividend risk.

Expected impact

Downward pressure, possible further share decline

Evidence & confidence

Revenue contraction, margin pressure and unsustainable dividend suggest weaker outlook.

Market effects

Consumer staples may face valuation compression as dividend‑paying peers see earnings weakness.

US and UK staple markets could see investor caution.

Highlights broader challenges for dividend‑focused strategies worldwide.

Counterpoint

Deep discount may lure value investors betting on a turnaround and cost cuts.

Key entities

  • Campbell Soup

    US-listed consumer staples company reporting earnings and dividend reset.

  • SEC

    U.S. Securities and Exchange Commission, source of the 10-K and 10-Q filings.

Related articles

$CPBHighAI 8/10

Campbell’s (CPB) Slashes Its Dividend To Fund A Brutal Reset

Campbell Soup Company (CPB) cut its dividend by over a third during its Q4 2026 earnings call, citing falling sales and profits. The company plans a multiyear rebuild, focusing on its soup business and cost savings. Net sales fell 8% to $2.137 billion, and adjusted EPS dropped to $0.39. Snacks segment saw a 6% decline in organic sales. Management expects challenges in Q1 2027.

$CEGMed

US District Court Strips Away Insane JH Campbell Fake Emergency Order

A US District Court ruled that the Trump administration's emergency order to keep the J.H. Campbell coal plant operating was unlawful. The court sided with Michigan and other states, finding the federal government overstepped its authority. Consumers Energy, the plant's owner, plans to replace it with methane, solar, and battery storage. Ratepayers in the MISO area have spent over $248 million to keep the plant running, with no immediate need for its electricity. Earthjustice and other climate o

$CPBMedAI 8/10

Food Exec Brief: Job Cuts at Campbell's, Record Low FDA Inspections, and Sugar Suppliers Sued

Campbell's (CPB) is cutting 13% of its workforce and closing two snack plants to save $500M by FY2030, following a 33% drop in net income and a 12% Q4 snacks decline. FDA foreign food inspections dropped 35% from 2019 levels to 1,140 sites in FY2025. General Mills (GIS), Mars, and McKee Foods sued sugar suppliers United Sugar and ASR Group for alleged price-fixing from 2017 to 2024.

$CPBHighAI 8/10

Campbell (CPB) Q4 2026 Earnings Call Transcript

Campbell Soup (CPB) reported Q4 2026 net sales of $2.137B, down 8% YoY, with adjusted EPS at $0.39. The company cut its dividend by 36% to reduce debt and launched a $500M cost-savings program. FY 2027 guidance includes a 4-2% organic net sales decline and adjusted EPS of $1.65-$1.80. Management expects inflation to persist and margins to shrink.

$CPBMed

Campbell’s (CPB) Turnaround Bid Faces a Tough Test as Costs and Weak Demand Persist

Campbell’s (CPB) is implementing a $500M cost-savings plan to improve margins amid declining sales. Q2 sales fell 8% to $2.1B, and the company reported a $69M loss. Campbell’s cut jobs, closed plants, and reduced its dividend. Management expects sales to decline further but aims to stabilize the business. Analysts expect fiscal 2027 adjusted EPS of $1.65-$1.80, below estimates. Investors are divided, with some increasing positions and others shorting the stock.